Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > # 1 on bullboards today

<< Previous

Bullboard Posts

Next >>

Comment by menoalittleon Dec 21, 2024 11:07pm

115 Views

Post# 36373997

RE:RE:RE:RE:# 1 on bullboards today

There's a way of looking at the data that probably makes Ruvidar more likely to receive AA than BTD... but I'm not thinking or saying it would be before BTD. Just, more likely when they eventually do apply for it. (Hopefully sooner in 2025 rather than later in 2025.)

<< Previous

Bullboard Posts

Next >>

Critical materials crisis: Diversifying away from China’s monopoly